华仁药业股价涨至3.32元，融资净买入356.62万元

Core Viewpoint - Huarun Pharmaceutical's stock price has recently increased, indicating active financing transactions and heightened market participation [1] Stock Performance - On February 24, 2026, Huarun Pharmaceutical's stock closed at 3.29 yuan, with a daily increase of 2.81% and a trading volume of 91.76 million yuan [1] - The net outflow of main funds was 6.517 million yuan, while the financing purchase amount reached 13.2529 million yuan, resulting in a net financing purchase of 3.5662 million yuan [1] - The financing balance stood at 299 million yuan, with 11 out of the last 20 trading days showing net purchases, reflecting high market participation [1] - As of February 25, 2026, the stock price further rose to 3.32 yuan, with a daily increase of 0.91% and a trading volume of 52.81 million yuan, resulting in a turnover rate of 1.34% [1] Recent Events - As of February 10, 2026, the number of Huarun Pharmaceutical shareholders was 39,300, an increase of 400 from January 30, representing a growth rate of 1.03%, although the average shareholding per account slightly decreased [1] - On the same day, the company's margin trading balance increased by 1.21% compared to the previous day, indicating enhanced activity [1]